Eric D. Strobel
Fox Chase Cancer Center(US)
Publications by Year
Research Areas
Poxvirus research and outbreaks, Diabetes Treatment and Management, Herpesvirus Infections and Treatments, Pancreatic function and diabetes, Chemical Synthesis and Analysis
Most-Cited Works
- → Discovery of a Type III Inhibitor of LIM Kinase 2 That Binds in a DFG-Out Conformation(2014)66 cited
- → Improved Solution- and Solid-Phase Preparation of Hydroxamic Acids from Esters(2005)64 cited
- → Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes(2017)64 cited
- → LX2761, a Sodium/Glucose Cotransporter 1 Inhibitor Restricted to the Intestine, Improves Glycemic Control in Mice(2017)34 cited
- → (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors with Broad Antiproliferative Activity against Tumor Cells(2005)34 cited
- → Rationally designed non-peptides: Variously substituted piperazine libraries for the discovery of bradykinin antagonists and other G-protein-coupled receptor ligands(1996)30 cited
- → Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads(2010)29 cited
- → Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitor(2019)24 cited
- → LP‐925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2(2015)13 cited
- → Mutation and structure guided discovery of an antiviral small molecule that mimics an essential C-Terminal tripeptide of the vaccinia D4 processivity factor(2018)12 cited